Herbalife Ltd. (HLF) stock
HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3042% below fair value
$15.57−0.58 (-3.59%)
Close on Nov 17, 2026Market cap $1.63BP/E 10.0Yield –
Herbalife EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Herbalife's EPS for the twelve months ending Jun 30, 2026 was $1.55, down 51.1% year over year. For fiscal 2025 it was $2.20, down 12.0% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $4.13 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.20 | -12.0% |
| FY2024 | Dec 31, 2024 | $2.50 | +76.1% |
| FY2023 | Dec 31, 2023 | $1.42 | -56.0% |
| FY2022 | Dec 31, 2022 | $3.23 | -21.8% |
| FY2021 | Dec 31, 2021 | $4.13 | +49.1% |
| FY2020 | Dec 31, 2020 | $2.77 | +25.9% |
| FY2019 | Dec 31, 2019 | $2.20 | +11.1% |
| FY2018 | Dec 31, 2018 | $1.98 | +53.5% |
| FY2017 | Dec 31, 2017 | $1.29 | -14.6% |
| FY2016 | Dec 31, 2016 | $1.51 | -23.9% |
| FY2015 | Dec 31, 2015 | $1.99 | +16.8% |
| FY2014 | Dec 31, 2014 | $1.70 | -30.8% |
| FY2013 | Dec 31, 2013 | $2.46 | +24.6% |
| FY2012 | Dec 31, 2012 | $1.97 | +18.7% |
| FY2011 | Dec 31, 2011 | $1.66 | +43.1% |
| FY2010 | Dec 31, 2010 | $1.16 | +44.1% |
| FY2009 | Dec 31, 2009 | $0.81 | -4.2% |
| FY2008 | Dec 31, 2008 | $0.84 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.25 | -152.1% |
| Q1 FY2026 | Mar 31, 2026 | $0.57 | +16.3% |
| Q4 FY2025 | Dec 31, 2025 | $0.81 | -53.4% |
| Q3 FY2025 | Sep 30, 2025 | $0.42 | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $0.48 | +860.0% |
| Q1 FY2025 | Mar 31, 2025 | $0.49 | +104.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.74 | +1640.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.46 | +7.0% |
| Q2 FY2024 | Jun 30, 2024 | $0.05 | -91.7% |
| Q1 FY2024 | Mar 31, 2024 | $0.24 | -17.2% |
| Q4 FY2023 | Dec 31, 2023 | $0.10 | -81.8% |
| Q3 FY2023 | Sep 30, 2023 | $0.43 | -48.2% |
| Q2 FY2023 | Jun 30, 2023 | $0.60 | -31.8% |
| Q1 FY2023 | Mar 31, 2023 | $0.29 | -69.8% |
| Q4 FY2022 | Dec 31, 2022 | $0.55 | +48.6% |
| Q3 FY2022 | Sep 30, 2022 | $0.83 | -23.9% |
| Q2 FY2022 | Jun 30, 2022 | $0.88 | -32.8% |
| Q1 FY2022 | Mar 31, 2022 | $0.96 | -27.8% |
| Q4 FY2021 | Dec 31, 2021 | $0.37 | -37.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.09 | +4.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.31 | +59.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.33 | +315.6% |
| Q4 FY2020 | Dec 31, 2020 | $0.59 | +47.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.04 | +79.3% |
| Q2 FY2020 | Jun 30, 2020 | $0.82 | +51.9% |
| Q1 FY2020 | Mar 31, 2020 | $0.32 | -51.5% |
| Q4 FY2019 | Dec 31, 2019 | $0.40 | +17.6% |
| Q3 FY2019 | Sep 30, 2019 | $0.58 | +18.4% |
| Q2 FY2019 | Jun 30, 2019 | $0.54 | -12.9% |
| Q1 FY2019 | Mar 31, 2019 | $0.66 | +22.2% |
| Q4 FY2018 | Dec 31, 2018 | $0.34 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.49 | +48.5% |
| Q2 FY2018 | Jun 30, 2018 | $0.62 | -23.5% |
| Q1 FY2018 | Mar 31, 2018 | $0.54 | +10.2% |
| Q4 FY2017 | Dec 31, 2017 | -$0.43 | -174.1% |
| Q3 FY2017 | Sep 30, 2017 | $0.33 | -34.7% |
| Q2 FY2017 | Jun 30, 2017 | $0.81 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.49 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.58 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.51 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?